• Vizient acquired SxanPro, a healthcare inventory technology platform backed by Golden Vision Capital Americas, in a deal that closed Sept. 17, 2026.
• SxanPro provides procedural inventory intelligence using mobile technology, proprietary analytics, and FDA Unique Device Identifier data to cut waste and costs.
• Vizient plans to integrate SxanPro into its Spend Management platform to broaden adoption across its provider network.
• Vizient serves more than two-thirds of U.S. acute care providers, managing a contract portfolio tied to about $168 billion in annual purchasing volume.
• Golden Vision Capital Americas invested in SxanPro in March 2023 to fund growth; financial terms of the sale were not disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Golden Vision Capital Americas LLC published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.